COVID-19, the disease caused by SARS-CoV-2, is a highly contagious disease. The World Health Organization has declared the ongoing outbreak to be a global public health emergency. Currently, the research on SARS-CoV-2 is in its primary stages. Based on current published evidence, this review systematically summarizes the epidemiology, clinical characteristics, diagnosis, treatment and prevention of COVID-19. It is hoped that this review will help the public to recognize and deal with SARS-CoV-2, and provide a reference for future studies. (c) 2020 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
基金：
National Natural Science Foundation of PRCNational Natural Science Foundation of China (NSFC) [81800609]
第一作者单位：[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430030, Peoples R China;[2]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Blood Purificat, Wuhan, Peoples R China;
通讯作者：
通讯机构：[1]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Nephrol, Wuhan 430030, Peoples R China;[2]Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Ctr Blood Purificat, Wuhan, Peoples R China;
推荐引用方式(GB/T 7714)：
Wang Lisheng,Wang Yiru,Ye Dawei,et al.Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence[J].INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS.2020,55(6):105948.doi:10.1016/j.ijantimicag.2020.105948.
APA：
Wang, Lisheng,Wang, Yiru,Ye, Dawei&Liu, Qingquan.(2020).Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence.INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS,55,(6)
MLA：
Wang, Lisheng,et al."Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence".INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 55..6(2020):105948
